Formerly located in New Mexico, Indigo Medical moved to Palo Alto, CA. Subsequently acquired in 1996 by Johnson & Johnson, the firm is an operating subsiduary of that company committed to the development and marketing of minimally invasive treatment systems for urological disorders. In addition to the Indigo LASEROPTIC(tm) Treatment System, Indigo also markets THERASEED® radioactive seed implants for the treatment of prostate cancer.